HEALTH CARE:
PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS
Fulcrum Therapeutics, Inc. produces and distributes pharmaceutical products. The Company develops and produces drugs for transforming gene regulation in diseases. Fulcrum Therapeutics serves the healthcare sectors in the State of Massachusetts.
| Market Cap | 434.88 Million | Shares Outstanding | 27.403 Million | Avg 30-day Volume | 79.929 Thousand |
| P/E Ratio | Dividend Yield | EPS | -0.29 | ||
| Price/Sales | 579.84 | Price cash flow ratio | Price free cash flow ratio | -12.8 | |
| Book Value | 2.58 | Price to Tangible Book | 6.11 | Alpha | 0.05 |
| Short Interest Ratio | % Short Interest to Float | R-squared | 0.111044 | ||
| BETA | 2.02872 | 52-week High/Low | 22.96 / 4.37 | Stddev | 0.39422 |
| Q1 2020 | All Institutions | Hedge Funds 1 |
|---|---|---|
| Filers who had this stock in their top 10: | 3 | 0 (0.0%) |
| 13F Filers holding this stock: | 46 | 14 (0.92%) |
| Aggregate 13F shares on 03/31/2020: | 16.1 Million | 4.744 Million |
| Aggregate 13F shares on 12/31/2019: | 15.071 Million | 4.07 Million |
| Percent change: | 6.83% | 16.57% |
| Funds creating new positions: | 11 | 4 |
| Funds Adding to an existing position: | 23 | 6 |
| Funds closing out their position: | 3 | 2 |
| Funds reducing their position: | 5 | 3 |
| 1 hedge funds as identified by whalewisdom.com through public filings. | ||
| Fulcrum Therapeutics Inc Chart by YCharts | |
| Yahoo! Finance | finviz |
| SEC Web Site | SEC DEF 14A Filings |
Please sign in first
none
11 Thousand total shares from 7 transactions
5 Thousand total shares from 4 transactions
| Insider Name | Type | Last Reported Shares Held | Last Reported Date | Filings in past year |
|---|---|---|---|---|
|
520,125 | 2020-07-28 | 0 | |
|
4,626,389 | 2020-07-24 | 0 | |
|
GOULD ROBERT J SEE REMARKS |
|
534,845 | 2020-07-08 | 10 |
|
WALLACE OWEN B. CHIEF SCIENTIFIC OFFICER |
|
127,088 | 2020-07-08 | 7 |
|
91,253 | 2020-07-01 | 1 | |
|
5,840,107 | 2020-07-01 | 0 | |
|
CADAVID DIEGO SVP CLINICAL DEVELOPMENT |
|
65,714 | 2020-07-01 | 10 |
|
0 | 2020-06-11 | 1 | |
|
0 | 2020-06-11 | 1 | |
|
0 | 2020-06-11 | 1 | |
|
0 | 2020-06-11 | 1 | |
|
10,600 | 2020-06-04 | 2 | |
|
THOMSON PETER G. VP FINANCE & ACCOUNTING |
|
21,071 | 2020-05-11 | 3 |
|
1,419,900 | 2020-02-18 | 0 | |
|
STUART BRYAN CHIEF OPERATING OFFICER |
|
0 | 2020-01-23 | 1 |
|
5,962,202 | 2019-07-22 | 0 | |
|
559,821 | 2019-07-22 | 0 | |
|
464,285 | 2019-07-22 | 0 |
| Reporting Owners | Transaction Date | Transaction Code | Shares | Share Price | Acquired or Disposed | Shares Owned Following Transaction | Combined shares owned after filing | Direct/Indirect Ownership | 10b-5 |
|---|---|---|---|---|---|---|---|---|---|
| 2020-07-08 | S | 2,951 | $20.00 | d | 127,088 | 127,088.00 | direct | yes | |
| 2020-07-08 | S | 2,500 | $20.00 | d | 534,845 | 534,845.00 | direct | yes | |
| 2020-07-08 | M | 2,951 | $7.84 | a | 130,039 | 127,088.00 | direct | yes | |
| 2020-07-08 | M | 2,951 | d | 81,942 | 127,088.00 | direct | yes | ||
| 2020-07-01 | S | 1,071 | $18.30 | d | 65,714 | 65,714.00 | direct | yes | |
| 2020-06-30 | M | 141 | d | 84,893 | 127,088.00 | direct | yes | ||
| 2020-06-30 | S | 141 | $20.00 | d | 127,088 | 127,088.00 | direct | yes | |
| 2020-06-30 | M | 141 | $7.84 | a | 127,229 | 127,088.00 | direct | yes | |
| 2020-06-25 | S | 2,500 | $20.80 | d | 537,345 | 537,345.00 | direct | yes | |
| 2020-06-25 | M | 1,459 | $4.83 | a | 68,244 | 66,785.00 | direct | yes | |
| 2020-06-25 | M | 1,459 | d | 12,277 | 66,785.00 | direct | yes | ||
| 2020-06-25 | S | 1,459 | $22.00 | d | 66,785 | 66,785.00 | direct | yes | |
| 2020-06-11 | A | 9,285 | a | 9,285 | 0.00 | direct | |||
| 2020-06-11 | A | 9,285 | a | 9,285 | 0.00 | direct | |||
| 2020-06-11 | A | 9,285 | a | 9,285 | 0.00 | direct | |||
| 2020-06-11 | A | 9,285 | a | 9,285 | 0.00 | direct | |||
| 2020-06-11 | A | 9,285 | a | 9,285 | 0.00 | direct | |||
| 2020-06-10 | M | 401 | $4.83 | a | 67,186 | 66,785.00 | direct | yes | |
| 2020-06-10 | M | 401 | d | 13,736 | 66,785.00 | direct | yes | ||
| 2020-06-10 | S | 401 | $22.00 | d | 66,785 | 66,785.00 | direct | yes |
| Code | Definition |
|---|---|
| A | Grant, award or other acquisition pursuant to Rule 16b-3(d) |
| C | Conversion of derivative security |
| D | Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 |
| G | Bona fide gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities |
| J | Other acquisition or disposition |
| L | Small acquisition under Rule 16a-6 |
| M | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
| O | Exercise of out-of-the-money derivative security |
| P | Open market or private purchase of non-derivative or derivative security |
| S | Open market or private sale of non-derivative or derivative security |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| W | Acquisition or disposition by will or the laws of descent and distribution |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |
